Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue	$ 1,362,163	$ 7,564
Cost of revenue	602,083	46,577
Gross profit (loss)	760,080	(39,013)
Operating expenses:
Research and development	642,546	421,887
Selling, general and administrative	5,696,211	1,291,765
Total operating expenses	6,338,757	1,713,652
Loss from operations	(5,578,677)	(1,752,665)
Other expenses	(20,931)	0
Change in fair value of warrant liability	(23,123)	0
Change in fair value of derivative liability	2,983,100	0
Change in fair value of earnout liability	(1,060,000)	0
Interest expense, net	(598,959)	(130,282)
Net loss and comprehensive loss	$ (4,298,590)	$ (1,882,947)
Net loss per share, basic (in dollars per share)	$ (0.33)	$ (0.20)
Net loss per share, diluted (in dollars per share)	$ (0.33)	$ (0.20)
Weighted-average number of common shares used in computing net loss per common share, basic (in shares)	13,225,553	9,517,098
Weighted-average number of common shares used in computing net loss per common share, diluted (in shares)	13,225,553	9,517,098